Viewing Study NCT04802161

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:44 PM
Ignite Modification Date: 2026-02-10 @ 11:10 AM
Study NCT ID: NCT04802161
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-19
First Post: 2021-03-16
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Acute Myeloid Leukemia Post Cytotoxic Therapy View
None Acute Myeloid Leukemia With Multilineage Dysplasia View
None Chronic Myelomonocytic Leukemia View
None Myelodysplastic Syndrome View
None Myeloproliferative Neoplasm View
Keywords: